Synthesis and Characterization of Novel Benzimidazolium Type NHC Molecule and Its Silver Complex and Their Theoretical Analysis for Potential Anti-Cancer Activity
Öz
N-heterocyclic carbenes have initially attracted great attention of the chemists in consequence of their catalytic activity. The favorable results were also obtained in bioactivity studies for N-heterocyclic carbenes, and their transition metal complexes in following years. Theoretical methods deliver beneficial data about the several activities of molecules. One of them is the frontier orbital analysis, which supplies data about the reactivity of molecules. Another method is investigation of the molecular activity against crystals of certain macromolecules using molecular docking methods. In this study, novel 1-allyl-3-(cyclohexylmethyl)benzimidazoliumbromide and bromo[1-allyl-3-(cyclohexylmethyl)benzimidazolium-2-ylidene]silver(I) were synthesized and characterized. The characterizations were also supported by spectroscopical and theoretical methods. In order to have foresight about the bioactivities of these molecules, molecular docking methods were used to get information about the interactions between molecules and VEGFR-2, which regulates the angiogenesis, and DNA.
Anahtar Kelimeler
N-Heterocyclic Carbenes, VGEFR-2, Silver Molecules, Molecular Docking, DFT
Kaynakça
- Aher, S. B., Muskawar, P. N., Thenmozhi, K., and Bhagat, P. R. (2014). Recent developments of metal N-heterocyclic carbenes as anticancer agents. European Journal of Medicinal Chemistry, 81, 408-419.
- Becke, A. D. (1988). Density-functional exchange-energy approximation with correct asymptotic behavior. Physical review A, 38(6), 3098.
- Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249-257.
- Choudhary, V., Bhatt, A., Dash, D., and Sharma, N. (2019). DFT calculations on molecular structures, HOMO–LUMO study, reactivity descriptors and spectral analyses of newly synthesized diorganotin (IV) 2‐chloridophenylacetohydroxamate complexes. Journal of Computational Chemistry, 40(27), 2354-2363.
- Dias, S., Hattori, K., Zhu, Z., Heissig, B., Choy, M., Lane, W., ... and Rafii, S. (2000). Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. The Journal of Clinical Investigation, 106(4), 511-521.
- Diez-Gonzalez, S., Marion, N., and Nolan, S. P. (2009). N-heterocyclic carbenes in late transition metal catalysis. Chemical Reviews, 109(8), 3612-3676.
- Drew, H. R., Wing, R. M., Takano, T., Broka, C., Tanaka, S., Itakura, K., and Dickerson, R. E. (1981). Structure of a B-DNA dodecamer: conformation and dynamics. Proceedings of the National Academy of Sciences, 78(4), 2179-2183.
- El-Adl, K., El-Helby, A. G. A., Sakr, H., Eissa, I. H., El-Hddad, S. S., and Shoman, F. M. (2020). Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme. Bioorganic Chemistry, 102, 104059.
- Ferrara, N. (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocrine reviews, 25(4), 581-611.
- Ferrara, N. (2009). Vascular endothelial growth factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 789-791.
kapsamında lisanslanmıştır.